Related references
Note: Only part of the references are listed.Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study
Ndivhuho A. Makhado et al.
LANCET INFECTIOUS DISEASES (2018)
Drug resistance mechanisms and novel drug targets for tuberculosis therapy
Md Mahmudul Islam et al.
JOURNAL OF GENETICS AND GENOMICS (2017)
Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
Jun Chen et al.
BMC INFECTIOUS DISEASES (2017)
Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex
Zenda L. Berrada et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Detection of Drug-Resistant Tuberculosis by Xpert MTB/RIF in Swaziland
Elisabeth Sanchez-Padilla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from South-central in China
Xiao-li Yu et al.
JOURNAL OF ANTIBIOTICS (2014)
Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis
F. B. Jamieson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Armand Van Deun et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations
Leen Rigouts et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
The Beginning of the rpoB Gene in Addition to the Rifampin Resistance Determination Region Might Be Needed for Identifying Rifampin/Rifabutin Cross-Resistance in Multidrug-Resistant Mycobacterium tuberculosis Isolates from Southern China
Yaoju Tan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis
Gilman Kit Hang Siu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin
Anna Zaczek et al.
BMC MICROBIOLOGY (2009)
Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis
Said H. Abbadi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
High-Level Rifampin Resistance Correlates with Multiple Mutations in the rpoB Gene of Pulmonary Tuberculosis Isolates from the Afghanistan Border of Iran
Ahmad Reza Bahrmand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
A. Van Deun et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
Dick Menzies et al.
PLOS MEDICINE (2009)
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates
D Hillemann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Evolution of drug resistance in Mycobacterium tuberculosis:: Clinical and molecular perspective
SH Gillespie
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
A Somoskovi et al.
RESPIRATORY RESEARCH (2001)
Share Paper
